Provided by Tiger Trade Technology Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

11.33
-1.0900-8.78%
Post-market: 11.400.0700+0.62%19:30 EDT
Volume:299.63K
Turnover:3.40M
Market Cap:3.84B
PE:-536.97
High:11.39
Open:11.34
Low:11.19
Close:12.42
52wk High:12.60
52wk Low:6.28
Shares:339.00M
Float Shares:272.00M
Volume Ratio:2.20
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0211
EPS(LYR):-0.0211
ROE:7.36%
ROA:2.71%
PB:7.88
PE(LYR):-536.97

Loading ...

Telix to Host R&D Day in New York City on September 22, 2026

GlobeNewswire
·
Aug 05

Telix Stock Price Weakness Could Be Hiding A Growth Story

Simply Wall St.
·
Aug 04

3 ASX Growth Companies With High Insider Ownership Growing Earnings Up To 44%

Simply Wall St.
·
Aug 04

How Investors May Respond To Telix Pharmaceuticals (ASX:TLX) Upgraded FY26 Guidance And Pipeline Milestones

Simply Wall St.
·
Aug 02

Telix Stock And Two Fast Growing ASX Shares With High Insider Ownership

Simply Wall St.
·
Aug 01

Telix H1 2026 Results: Investor Webcast Notification

GlobeNewswire
·
Jul 31

Telix Pharmaceuticals Stock And 2 Fast Growing Insider Owned ASX Shares

Simply Wall St.
·
Jul 31

Telix Stock And 2 Australian Growth Shares With High Insider Ownership

Simply Wall St.
·
Jul 28

3 Australian Growth Stocks Where Insider Ownership Could Matter Most

Simply Wall St.
·
Jul 26

Telix Stock And Other Fast Growing Insider Owned Shares Worth A Closer Look

Simply Wall St.
·
Jul 24

What Telix Pharmaceuticals (ASX:TLX)'s Upgraded US$1 Billion FY26 Outlook Means For Shareholders

Simply Wall St.
·
Jul 24

Jarden Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)

TIPRANKS
·
Jul 24

3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.
·
Jul 23

Analysts Have Conflicting Sentiments on These Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and CSL (OtherCMXHF)

TIPRANKS
·
Jul 23

3 Australian Growth Stocks Where Insider Ownership Signals Stronger Conviction

Simply Wall St.
·
Jul 22

Analysts Offer Insights on Healthcare Companies: Compugen (CGEN), Telix Pharmaceuticals (OtherTLPPF) and Sarepta Therapeutics (SRPT)

TIPRANKS
·
Jul 22

TLX591-Tx ProstACT SELECT Study Published in Cancers Journal

GlobeNewswire
·
Jul 22

Reported Earlier, Telix Q2 Revenue $247M Up From $204M, With Precision Medicine Up 30% YoY

Benzinga Earnings
·
Jul 21

Telix Pharmaceuticals Carries Meaningful Upside on Potential Product Approvals, Jefferies Says

MT Newswires Live
·
Jul 21

3 Australian Growth Stocks Trading Below Fair Value With Strong Insider Backing

Simply Wall St.
·
Jul 21